BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7670119)

  • 21. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L; Laporte JP; Mary JY; Lopez M; Lemonnier MP; Stachowiak J; Benitez O; Deloux J; Najman A; Salmon C
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Importance of marrow dose on posttransplant outcome in acute leukemia: models derived from patients autografted with mafosfamide-purged marrow at a single institution.
    Gorin NC; Labopin M; Laporte JP; Douay L; Lopez M; Lesage S; Fouillard L; Isnard F; Jouet JP; Bellal N; Perot C; Van Den Akker J; Bauters F; Najman A
    Exp Hematol; 1999 Dec; 27(12):1822-30. PubMed ID: 10641600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide.
    Skorski T; Nieborowska-Skorska M; Barletta C; Malaguarnera L; Szcyzlik C; Chen ST; Lange B; Calabretta B
    J Clin Invest; 1993 Jul; 92(1):194-202. PubMed ID: 8325984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
    Makrynikola V; Kabral A; Bradstock KF
    Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fractionation of chronic myelogenous leukemia marrow cells by stroma adherence: implications for marrow purging.
    Rizzoli V; Mangoni L; Piovani G; Garau D; Caramatti C; Almici C; Carlo-Stella C
    Leuk Lymphoma; 1993; 11 Suppl 1():109-12. PubMed ID: 8251884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of a reliable experimental procedure for bone marrow purging with mafosfamide (ASTA Z 7557).
    Douay L; Mary JY; Giarratana MC; Najman A; Gorin NC
    Exp Hematol; 1989 Jun; 17(5):429-32. PubMed ID: 2653856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J; Fehér I
    Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow.
    Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V
    Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Cottafavi L; Dotti GP; Rizzoli V
    Bone Marrow Transplant; 1994 Sep; 14(3):425-32. PubMed ID: 7994267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
    Kramer B; Makrynikola V; Bradstock K
    Prog Clin Biol Res; 1992; 377():41-7. PubMed ID: 1438438
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
    Olivieri A; Poloni A; Montanari M; Cantori I; Corvatta L; Masia MC; Curzi L; Mancini S; Leoni P
    J Hematother; 1997 Apr; 6(2):137-44. PubMed ID: 9131443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Philadelphia leukemia in severe combined immunodeficient mice by combination of cyclophosphamide and bcr/abl antisense oligodeoxynucleotides.
    Skorski T; Nieborowska-Skorska M; Wlodarski P; Perrotti D; Hoser G; Kawiak J; Majewski M; Christensen L; Iozzo RV; Calabretta B
    J Natl Cancer Inst; 1997 Jan; 89(2):124-33. PubMed ID: 8998181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the sensitivity of normal and leukaemic myeloid progenitors to in-vitro incubation with cytotoxic drugs: a study of pharmacological purging.
    Singer CR; Linch DC
    Leuk Res; 1987; 11(11):953-9. PubMed ID: 3320579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autologous transplantation for chronic myelogenous leukemia with mafosfamide-treated marrow.
    Rizzoli V; Mangoni L; Almici C; Caramatti C; Dotti GP; Carlo-Stella C
    Stem Cells; 1993 Oct; 11 Suppl 3():25-30. PubMed ID: 8298474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cumulative chemotherapy increases mafosfamide toxicity for normal progenitor cells in AML patients: rationale for cryopreserving adapted-dose purged marrow early in first complete remission.
    Martin H; Bruecher J; Claudé R; Hoelzer D
    Bone Marrow Transplant; 1993 Nov; 12(5):495-9. PubMed ID: 8298560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
    Yang H; Eaves C; de Lima M; Lee MS; Champlin RE; McMannis JD; Robinson SN; Niu T; Decker WK; Xing D; Ng J; Li S; Yao X; Eaves AC; Jones R; Andersson BS; Shpall EJ
    Bone Marrow Transplant; 2006 Mar; 37(6):575-82. PubMed ID: 16435011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia.
    Rowley SD; Jones RJ; Piantadosi S; Braine HG; Colvin OM; Davis J; Saral R; Sharkis S; Wingard J; Yeager AM
    Blood; 1989 Jul; 74(1):501-6. PubMed ID: 2665843
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
    Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
    Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow support.
    Shpall EJ; Stemmer SM; Hami L; Franklin WA; Shaw L; Bonner HS; Bearman SI; Peters WP; Bast RC; McCulloch W
    Blood; 1994 Jun; 83(11):3132-7. PubMed ID: 8193351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.